Yahoo Finance

Key Insights

• AlzChem Group to hold its Annual General Meeting on 7th of May

• Salary of €315.0k is part of CEO Andreas Niedermaier's total remuneration

• The overall pay is 173% above the industry average

• Over the past three years, AlzChem Group's EPS grew by 21% and over the past three years, the total shareholder return was 104%

Performance at AlzChem Group AG (ETR:ACT) has been reasonably good and CEO Andreas Niedermaier has done a decent job of steering the company in the right direction. As shareholders go into the upcoming AGM on 7th of May, CEO compensation will probably not be their focus, but rather the steps management will take to continue the growth momentum. However, some shareholders will still be cautious of paying the CEO excessively.

Check out our latest analysis for AlzChem Group

Comparing AlzChem Group AG's CEO Compensation With The Industry

Our data indicates that AlzChem Group AG has a market capitalization of €464m, and total annual CEO compensation was reported as €1.5m for the year to December 2023. That's a notable increase of 84% on last year. We think total compensation is more important but our data shows that the CEO salary is lower, at €315k.

In comparison with other companies in the German Chemicals industry with market capitalizations ranging from €187m to €749m, the reported median CEO total compensation was €552k. Hence, we can conclude that Andreas Niedermaier is remunerated higher than the industry median.

Speaking on an industry level, nearly 30% of total compensation represents salary, while the remainder of 70% is other remuneration. AlzChem Group pays a modest slice of remuneration through salary, as compared to the broader industry. It's important to note that a slant towards non-salary compensation suggests that total pay is tied to the company's performance.

AlzChem Group AG's Growth

AlzChem Group AG's earnings per share (EPS) grew 21% per year over the last three years. In the last year, its revenue changed by just 0.7%.

This demonstrates that the company has been improving recently and is good news for the shareholders. It's always a tough situation when revenues are not growing, but ultimately profits are more important. Looking ahead, you might want to check this free visual report on analyst forecasts for the company's future earnings..

Has AlzChem Group AG Been A Good Investment?

We think that the total shareholder return of 104%, over three years, would leave most AlzChem Group AG shareholders smiling. This strong performance might mean some shareholders don't mind if the CEO were to be paid more than is normal for a company of its size.